FXYD2 and autosomal dominant medullary cystic kidney disease with or without hyperuricemia: In the first description of electrolyte defects in ADTKD-HNF1β patients by Adalat and colleagues, FXYD2 was identified as a transcriptional target in the distal convoluted tubule (DCT) (Fig. 1) [5].